We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
-16.17%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.02B
AUM Growth
-$508M
Cap. Flow
-$68.9M
Cap. Flow %
-3.42%
Top 10 Hldgs %
30.76%
Holding
262
New
5
Increased
58
Reduced
132
Closed
38

Sector Composition

Rank Sector Weight
1 Technology 19.3%
2 Financials 15.56%
3 Healthcare 11.65%
4 Consumer Staples 7.47%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
201
Emerson Electric
EMR
$83.8B
$225K 0.01%
4,712
+812
+21% +$53.5K
CMF icon
202
iShares California Muni Bond ETF
CMF
$4.54B
$218K 0.01%
3,600
TDOC icon
203
Teladoc Health
TDOC
$1.21B
$213K 0.01%
+1,377
New +$160K
VFH icon
204
Vanguard Financials ETF
VFH
$13.5B
$213K 0.01%
4,206
-551
-12% -$37.5K
TREE icon
205
LendingTree
TREE
$456M
$211K 0.01%
1,150
VHT icon
206
Vanguard Health Care ETF
VHT
$18.1B
$211K 0.01%
1,272
-75
-6% -$13.7K
FBGX
207
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$201K 0.01%
866
-30
-3% -$9.55K
IWS icon
208
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$200K 0.01%
3,125
-869
-22% -$74.3K
SAN icon
209
Banco Santander
SAN
$201B
$194K 0.01%
+86,097
New +$295K
PI icon
210
Impinj
PI
$4.56B
$186K 0.01%
11,120
-275
-2% -$7.42K
NTNX icon
211
Nutanix
NTNX
$15.9B
$158K 0.01%
+10,000
New +$281K
CDMO
212
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$153K 0.01%
30,000
-37,000
-55% -$224K
SLB icon
213
SLB Ltd
SLB
$73.1B
$151K 0.01%
11,194
-1,640
-13% -$47.5K
UMH
214
UMH Properties
UMH
$1.29B
$151K 0.01%
13,896
MTNB icon
215
Matinas BioPharma
MTNB
$1.96M
$86K ﹤0.01%
2,850
AGEN
216
Agenus
AGEN
$311M
$81K ﹤0.01%
1,678
F icon
217
Ford
F
$57.9B
$56K ﹤0.01%
11,500
DAKT icon
218
Daktronics
DAKT
$949M
$41K ﹤0.01%
40,989
APHA
219
DELISTED
Aphria Inc. Common Shares
APHA
$38K ﹤0.01%
12,500
NOK icon
220
Nokia
NOK
$50.9B
$31K ﹤0.01%
10,000
CATX icon
221
Perspective Therapeutics
CATX
$325M
$29K ﹤0.01%
5,482
FSTX
222
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$14K ﹤0.01%
3,829
PTN
223
Palatin Technologies
PTN
$14.2M
$11K ﹤0.01%
20
ADP icon
224
Automatic Data Processing
ADP
$106B
-1,375
Closed -$234K
AVGO icon
225
Broadcom
AVGO
$1.83T
-6,970
Closed -$220K

Similar funds

Crestwood Advisors Group's Q1 2020 Portfolio in Review

As of Q1 2020, Crestwood Advisors Group held 262 positions worth $2.02B, down 20% from $2.52B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group withdrew a net $68.9M in Q1 2020, closing 38 positions and reducing 132 holdings. Its most notable exit was Hilton Worldwide, an estimated $29.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Crestwood Advisors Group opened a new position in SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) worth $26.3M.

  • Crestwood Advisors Group's largest Q1 2020 buy was SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML): 543,708 shares worth $26.3M.
  • Crestwood Advisors Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $20.9M increase.
  • Crestwood Advisors Group's biggest Q1 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $47.6M.
  • Crestwood Advisors Group fully exited Hilton Worldwide in Q1 2020, selling an estimated $29.7M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $2.02B portfolio in Q1 2020.
  • Crestwood Advisors Group opened 5 new positions and closed 38 in Q1 2020.
  • Crestwood Advisors Group's portfolio value fell 20% quarter-over-quarter to $2.02B.

Based on Crestwood Advisors Group's 13F filing for Q1 2020, filed 15 May 2020.